VAERS Explorer
Back to explore

Report #2901863

Received Jun 29, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
23 yrs
State
Recovered
Recovered
Vaccinated
Jun 11, 2026
Onset
Jun 11, 2026
Days to onset
0
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.UNK

Symptoms (1)

Unevaluable event

Symptom narrative

severe allergic reaction; This Spontaneous report was received from Consumer or other non health professional and referred to a/an 23-years-old Female Adult patient. The patient's concurrent condition included Dairy allergy The patient's past medications were not reported. The patient's concomitant medication included Epipen (Gabapentin) and Benadryl (Acrivastine). On 11-Jun-2026, the patient started therapy with sterile diluent solution for injection (Batch/Lot Number: 2053189) (Expiration date: 05-Mar-2028) (Dose Text: unknown). On 11-Jun-2026, the patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection (0.50 mL)Unknown Batch/Lot Number dose form was Injection (Dose Text: 0.5 mL). The patient started therapy with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection for the treatment of Varicella Vaccine, The patient started therapy with sterile diluent solution for injection for the treatment of prophylaxis, On 11-Jun-2026, the patient experienced severe allergic reaction (Hypersensitivity) (Severe). On 12-Jun-2026, the patient recovered from Hypersensitivity (Severe) . The action taken with Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection regarding Hypersensitivity was Not applicable with Not Applicable dechallenge and rechallenge results. The action taken with sterile diluent solution for injection regarding Hypersensitivity was Not applicable with Not Applicable dechallenge and rechallenge results. The Consumer or other non health professional considered the causality for the event Hypersensitivity to Varicella Virus Vaccine Live (Oka-Merck) powder and solvent for solution for injection was not reported, and the causality for the event Hypersensitivity to sterile diluent solution for injection was not reported, The Consumer or other non health professional considered the event Hypersensitivity to be non-serious

Current illness

Milk allergy

Other medications

EPIPEN; BENEDRY; Sterile diluent